-
1
-
-
84893426320
-
Dosing irregularities and self-treated hypoglycemia in type 2 diabetes: results from the Canadian cohort of an international survey of patients and healthcare professionals
-
Leiter LA, Boras D, Woo VC. Dosing irregularities and self-treated hypoglycemia in type 2 diabetes: results from the Canadian cohort of an international survey of patients and healthcare professionals. Can J Diabetes 2014; 38: 38–44.
-
(2014)
Can J Diabetes
, vol.38
, pp. 38-44
-
-
Leiter, L.A.1
Boras, D.2
Woo, V.C.3
-
2
-
-
84866268783
-
Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
-
Inzucchi SE, Bergenstal RM, Buse JB et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012; 35: 1364–1379.
-
(2012)
Diabetes Care
, vol.35
, pp. 1364-1379
-
-
Inzucchi, S.E.1
Bergenstal, R.M.2
Buse, J.B.3
-
3
-
-
84903552407
-
Type 1 diabetes through the life span: a position statement of the American Diabetes Association
-
Chiang JL, Kirkman MS, Laffel LM, Peters AL, Type 1 Diabetes Sourcebook Authors. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care 2014; 37: 2034–2054.
-
(2014)
Diabetes Care
, vol.37
, pp. 2034-2054
-
-
Chiang, J.L.1
Kirkman, M.S.2
Laffel, L.M.3
Peters, A.L.4
-
4
-
-
34547830134
-
Long-acting insulin analogs vs. NPH insulin (human isophane insulin) for type 2 diabetes mellitus
-
Apr 18
-
Horvath K, Jeitler K, Berghold A et al. Long-acting insulin analogs vs. NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database Syst Rev 2007: Apr 18;(2):CD005613.
-
(2007)
Cochrane Database Syst Rev
, Issue.2
, pp. CD005613
-
-
Horvath, K.1
Jeitler, K.2
Berghold, A.3
-
5
-
-
44949231427
-
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
-
Richter B, Bandeira-Echtler E, Bergerhoff K, Lerch CL. Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev 2008: 16;(2):CD006739.
-
(2008)
Cochrane Database Syst Rev
, vol.16
, Issue.2
, pp. CD006739
-
-
Richter, B.1
Bandeira-Echtler, E.2
Bergerhoff, K.3
Lerch, C.L.4
-
6
-
-
80155183665
-
Glucagon-like peptide analogs for type 2 diabetes mellitus
-
Shyangdan DS, Royle P, Clar C, Sharma P, Waugh N, Snaith A. Glucagon-like peptide analogs for type 2 diabetes mellitus. Cochrane Database Syst Rev 2011: 5;(10):CD006423.
-
(2011)
Cochrane Database Syst Rev
, vol.5
, Issue.10
, pp. CD006423
-
-
Shyangdan, D.S.1
Royle, P.2
Clar, C.3
Sharma, P.4
Waugh, N.5
Snaith, A.6
-
7
-
-
79960977048
-
Insulin detemir vs. insulin glargine for type 2 diabetes mellitus
-
Jul 6
-
Swinnen SG, Simon AC, Holleman F, Hoekstra JB, Devries JH. Insulin detemir vs. insulin glargine for type 2 diabetes mellitus. Cochrane Database Syst Rev 2011: Jul 6;(7):CD006383.
-
(2011)
Cochrane Database Syst Rev
, vol.6
, Issue.7
, pp. CD006383
-
-
Swinnen, S.G.1
Simon, A.C.2
Holleman, F.3
Hoekstra, J.B.4
Devries, J.H.5
-
9
-
-
84890313541
-
Understanding the economic burden of non-severe nocturnal hypoglycemic events: impact on work productivity, disease management, and resource utilization
-
Brod M, Wolden M, Christensen T, Bushnell DM. Understanding the economic burden of non-severe nocturnal hypoglycemic events: impact on work productivity, disease management, and resource utilization. Value Health 2013; 16: 1140–1149.
-
(2013)
Value Health
, vol.16
, pp. 1140-1149
-
-
Brod, M.1
Wolden, M.2
Christensen, T.3
Bushnell, D.M.4
-
10
-
-
84889805578
-
Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and well-being in insulin-treated patients with diabetes in seven European countries
-
Geelhoed-Duijvestijn PH, Pedersen-Bjergaard U, Weitgasser R, Lahtela J, Jensen MM, Ostenson CG. Effects of patient-reported non-severe hypoglycemia on healthcare resource use, work-time loss, and well-being in insulin-treated patients with diabetes in seven European countries. J Med Econ 2013; 16: 1453–1461.
-
(2013)
J Med Econ
, vol.16
, pp. 1453-1461
-
-
Geelhoed-Duijvestijn, P.H.1
Pedersen-Bjergaard, U.2
Weitgasser, R.3
Lahtela, J.4
Jensen, M.M.5
Ostenson, C.G.6
-
11
-
-
84890165658
-
Self-reported non-severe hypoglycemic events in Europe
-
Ostenson CG, Geelhoed-Duijvestijn P, Lahtela J, Weitgasser R, Markert JM, Pedersen-Bjergaard U. Self-reported non-severe hypoglycemic events in Europe. Diabet Med 2014; 31: 92–101.
-
(2014)
Diabet Med
, vol.31
, pp. 92-101
-
-
Ostenson, C.G.1
Geelhoed-Duijvestijn, P.2
Lahtela, J.3
Weitgasser, R.4
Markert, J.M.5
Pedersen-Bjergaard, U.6
-
12
-
-
33947704161
-
PREDICTIVE – a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycemia from the European cohort
-
Luddeke HJ, Sreenan S, Aczel S et al. PREDICTIVE – a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycemia from the European cohort. Diabetes Obes Metab 2007; 9: 428–434.
-
(2007)
Diabetes Obes Metab
, vol.9
, pp. 428-434
-
-
Luddeke, H.J.1
Sreenan, S.2
Aczel, S.3
-
13
-
-
84901235805
-
Incidence, worry and discussion about dosing irregularities and self-treated hypoglycemia amongst HCPs and patients with type 2 diabetes: results from the UK cohort of the Global Attitudes of Patient and Physicians (GAPP2) survey
-
Munro N, Barnett AH. Incidence, worry and discussion about dosing irregularities and self-treated hypoglycemia amongst HCPs and patients with type 2 diabetes: results from the UK cohort of the Global Attitudes of Patient and Physicians (GAPP2) survey. Int J Clin Pract 2014; 68: 692–699.
-
(2014)
Int J Clin Pract
, vol.68
, pp. 692-699
-
-
Munro, N.1
Barnett, A.H.2
-
14
-
-
18144388647
-
Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia
-
Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care 2005; 28: 1245–1249.
-
(2005)
Diabetes Care
, vol.28
, pp. 1245-1249
-
-
-
15
-
-
84873248938
-
The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries
-
Khunti K, Caputo S, Damci T et al. The safety and efficacy of adding once-daily insulin detemir to oral hypoglycaemic agents in patients with type 2 diabetes in a clinical practice setting in 10 countries. Diabetes Obes Metab 2012; 14: 1129–1136.
-
(2012)
Diabetes Obes Metab
, vol.14
, pp. 1129-1136
-
-
Khunti, K.1
Caputo, S.2
Damci, T.3
-
16
-
-
58149389215
-
Glucose control and vascular complications in veterans with type 2 diabetes
-
Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360: 129–139.
-
(2009)
N Engl J Med
, vol.360
, pp. 129-139
-
-
Duckworth, W.1
Abraira, C.2
Moritz, T.3
-
17
-
-
74949138626
-
The effects of baseline characteristics, glycaemia treatment approach, and glycated hemoglobin concentration on the risk of severe hypoglycemia: post-hoc epidemiological analysis of the ACCORD study
-
Miller ME, Bonds DE, Gerstein HC et al. The effects of baseline characteristics, glycaemia treatment approach, and glycated hemoglobin concentration on the risk of severe hypoglycemia: post-hoc epidemiological analysis of the ACCORD study. BMJ 2010; 340: b5444.
-
(2010)
BMJ
, vol.340
, pp. b5444
-
-
Miller, M.E.1
Bonds, D.E.2
Gerstein, H.C.3
-
18
-
-
45149133036
-
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
-
ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358: 2560–2572.
-
(2008)
N Engl J Med
, vol.358
, pp. 2560-2572
-
-
Patel, A.1
MacMahon, S.2
Chalmers, J.3
-
19
-
-
0027370108
-
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
-
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.
-
(1993)
N Engl J Med
, vol.329
, pp. 977-986
-
-
-
20
-
-
20444408424
-
Frequency and predictors of hypoglycemia in type 1 and insulin-treated type 2 diabetes: a population-based study
-
Donnelly LA, Morris AD, Frier BM et al. Frequency and predictors of hypoglycemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med 2005; 22: 749–755.
-
(2005)
Diabet Med
, vol.22
, pp. 749-755
-
-
Donnelly, L.A.1
Morris, A.D.2
Frier, B.M.3
-
21
-
-
84926670200
-
Frequency and predictors of confirmed hypoglycemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study
-
Cariou B, Fontaine P, Eschwege E et al. Frequency and predictors of confirmed hypoglycemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study. Diabetes Metab 2015; 41: 116–125.
-
(2015)
Diabetes Metab
, vol.41
, pp. 116-125
-
-
Cariou, B.1
Fontaine, P.2
Eschwege, E.3
-
22
-
-
34247871323
-
Risk of hypoglycemia in types 1 and 2 diabetes: effects of treatment modalities and their duration
-
UK Hypoglycemia Study Group. Risk of hypoglycemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007; 50: 1140–1147.
-
(2007)
Diabetologia
, vol.50
, pp. 1140-1147
-
-
-
23
-
-
84935511058
-
Prevalence and incidence of hypoglycemia in 532,542 people with type 2 diabetes on oral therapies and insulin: a systematic review and meta-analysis of population based studies
-
Edridge C, Dunkley A, Bodicoate D et al. Prevalence and incidence of hypoglycemia in 532,542 people with type 2 diabetes on oral therapies and insulin: a systematic review and meta-analysis of population based studies. PLoS One 2015; 10: e0126427.
-
(2015)
PLoS One
, vol.10
-
-
Edridge, C.1
Dunkley, A.2
Bodicoate, D.3
-
24
-
-
85032499505
-
Health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes
-
Content presented in poster at EASD 2015
-
Elliot L, Aronson R, Galstyan G et al. Health economic impact of hypoglycaemia in a global population of patients with insulin-treated diabetes. Diabetologia 2015; 58(Suppl. 1): S480 (Abstract 991). Content presented in poster at EASD 2015.
-
(2015)
Diabetologia
, vol.58
, pp. S480
-
-
Elliot, L.1
Aronson, R.2
Galstyan, G.3
-
25
-
-
84908352320
-
Hemoglobin A1c levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012
-
Karges B, Rosenbauer J, Kapellen T et al. Hemoglobin A1c levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012. PLoS Med 2014; 11: e1001742.
-
(2014)
PLoS Med
, vol.11
-
-
Karges, B.1
Rosenbauer, J.2
Kapellen, T.3
-
26
-
-
0036314189
-
Hypoglycemia-associated autonomic failure in advanced type 2 diabetes
-
Segel SA, Paramore DS, Cryer PE. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 2002; 51: 724–733.
-
(2002)
Diabetes
, vol.51
, pp. 724-733
-
-
Segel, S.A.1
Paramore, D.S.2
Cryer, P.E.3
-
27
-
-
33644664033
-
Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes
-
Cryer PE. Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 2005; 54: 3592–3601.
-
(2005)
Diabetes
, vol.54
, pp. 3592-3601
-
-
Cryer, P.E.1
|